ARM · Verdict

A summary of rules, not a profit forecast — don’t buy just because of a green verdict.

• ▼ P/S 42.7 vs peer median 16.9 — more expensive than peers
• ▼ FCF yield 0.4% vs peer median 0.8% — more expensive than peers
• ▲ Forward P/E 67.2 is below the current one — earnings growth expected

• ▼ Debt up 107% in 3 y
• ▲ Piotroski 6/8 — strong financial health
• ▼ Net margin fell: 19.6% → 18.4%
• ▲ Debt / equity 0.06 — moderate debt
• ▲ Free cash flow positive every year

• ▲ Revenue grows 22.5% per year (3 y)
• ▲ Earnings per share grows 18.5% per year (3 y)

• ▼ Over 6 mo weaker than its sector (XLK) by 15%
• ▼ Price below SMA200 — long-term downtrend
• ▲ SMA50 above SMA200 — trend up
• ▲ Over a year +24% vs S&P 500 +11% — stronger than the market

• ▼ Earnings in 2 d — the price may move sharply (≈ ±12.4%)
• ▼ Risk/reward 1:0.6 — the target is closer than the stop
• ▼ Volatility 80% per year — much higher than the market (13%)
• ▼ Max drawdown in the period -54% — deep
• ▼ Beta 3.79 — moves more than the market
• ▼ 12% of float is short — many bet on a decline

• ▲ Consensus of 40 analysts — buy
• ▲ Mean analyst target +41% from the current price
• ▲ Insiders buying over 6 mo

• ▲ S&P 500 above SMA200 — the market is in an uptrend
• ▲ Sector (XLK) above SMA200 — in an uptrend